Replies to post #1311 on Enanta Pharmaceuticals Inc (ENTA)

[DewDiligence]

It helps that the expected tax rate in FY2016 is only 27% (#msg-120398905).

[Rocky3]

Looks like Yahoo says that calendar year earnings are estimated at ~.30/sh and '17 earnings negative. Sure seems to low to me. If 3/31/16 quarter can repeat 12/31/15 royalty (and I think that they should be higher due to Japanese sales more than replacing the decline in the US, which is down ~20% QOQ at this point), there should be >.20/sh income.

Once again, I was very wrong.

I still think that ENTA can earn ~$1/sh+ in calander '16,

That is now looking very unlikely. It may be fortunate to break-even. Needs more Japanese and EU sales. We know that US sales are continuing down. I hope the ABBV guidance is at least close.

Is truly a 2nd generation story since it looks like 1st gen will not be enough to produce any income. Too bad. Will have to rethink the entire story